MedTrace Logo

Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics

NCT04010110 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2019-07-09

No results posted yet for this study

Summary

This study assesses the ocular toxicity in patients on high dose hydroxychloroquine (HCQ) as per the latest guidelines of the American Academy of Ophthalmology (AAO).

Conditions

  • Hydroxychloroquine Toxic Retinopathy

Interventions

DIAGNOSTIC_TEST

visual field testing (10-2), spectral domain ocular coherence tomography and Fundus auto-fluorescence

The diagnosis of toxic retinopathy was based on the positivity of at least two objective tests to confirm the subjective findings. The presence or absence of toxicity was recorded.

Sponsors & Collaborators

  • King Khalid University Hospital

    collaborator OTHER

  • The Eye Center and The Eye Foundation for Research in Ophthalmology

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2019-06-01
Completion
2019-06-01

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010110 on ClinicalTrials.gov